MedPath

Deferoxamine on neurological and radiological implications for cerebral hemorrhage

Phase 2
Conditions
level of consciousness.
Other coma, without documented Glasgow coma scale score, or with partial score reported
R40.244
Registration Number
IRCT20190325043107N30
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
42
Inclusion Criteria

Brain stroke
Spontaneous cerebral hemorrhage
Satisfaction to participate in the study

Exclusion Criteria

Requires brain surgery
Stroke over the last six months
Hypersensitivity to deferoxamine

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evel of consciousness. Timepoint: Before the intervention, one week and one month after the end of the intervention. Method of measurement: With the help of GCS criteria.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath